10-Q Filing

BIO GREEN MED SOLUTION, INC. CIK: 1130166 Q3 2012

Filing Information

Form Type	10-Q
Accession Number	`0001104659-12-078585`
Period End Date	20120930
Filing Date	20121116
Fiscal Year	2012
Fiscal Period	Q3
XBRL Instance	cycc-20120930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 116 Cash Flow Statement 104 Comprehensive Income 5

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1.21M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1.21M	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1.21M	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1.21M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.84M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$27.68M	USD	Point-in-time
Preferred stock, liquidation preference value (in dollars)	`PreferredStockLiquidationPreferenceValue`	$13.71B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.50M	USD	Point-in-time
Preferred stock, liquidation preference value (in dollars)	`PreferredStockLiquidationPreferenceValue`	$14.25B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.45M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.07M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.24M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$313.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$881.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.43M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$25.83M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$19.95M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7.75M	shares	Point-in-time
Property, plant and equipment (net)	`PropertyPlantAndEquipmentNet`	$140.00K	USD	Point-in-time
Property, plant and equipment (net)	`PropertyPlantAndEquipmentNet`	$167.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	7.75M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.43M	shares	Point-in-time
Long-term assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$433.00K	USD	Point-in-time
Total assets	`Assets`	$20.53M	USD	Point-in-time
Total assets	`Assets`	$26.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.72M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.64M	USD	Point-in-time
Accrued liabilities and other current liabilities	`AccruedLiabilitiesCurrent`	$4.18M	USD	Point-in-time
Accrued liabilities and other current liabilities	`AccruedLiabilitiesCurrent`	$4.13M	USD	Point-in-time
Economic rights	`WarrantsAndRightsOutstanding`	$1.07M	USD	Point-in-time
Other liabilities measured at fair value	`OtherLiabilitiesCurrent`	$20.00K	USD	Point-in-time
Other liabilities measured at fair value	`OtherLiabilitiesCurrent`	$71.00K	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$527.00K	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$438.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.30M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.50M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.50M	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized at December 31, 2011 and September 30, 2012; 1,213,142 shares issued and outstanding at December 31, 2011 and September 30, 2012. Aggregate preference in liquidation of $13,708,505 and $14,254,419 at December 31, 2011 and September 30, 2012, respectively	`PreferredStockValue`	$1.00K	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized at December 31, 2011 and September 30, 2012; 1,213,142 shares issued and outstanding at December 31, 2011 and September 30, 2012. Aggregate preference in liquidation of $13,708,505 and $14,254,419 at December 31, 2011 and September 30, 2012, respectively	`PreferredStockValue`	$1.00K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2011 and September 30, 2012; 7,745,779 and 8,434,292 shares issued and outstanding at December 31, 2011 and September 30, 2012, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2011 and September 30, 2012; 7,745,779 and 8,434,292 shares issued and outstanding at December 31, 2011 and September 30, 2012, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$276.50M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$278.65M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$51.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$57.00K	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-257.06M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-265.49M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$13.23M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$19.50M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$20.53M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$26.00M	USD	Point-in-time

Income Statement 116 line items

Line Item	Tag	Value	Unit	Period
Income (loss) from discontinued operations, tax, period presented	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	-	USD	3 Qtrs
Income (loss) from discontinued operations, tax, period presented	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	-	USD	1 Quarter
Income (loss) from discontinued operations, tax, period presented	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	-	USD	3 Qtrs
Income (loss) from discontinued operations, tax, period presented	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	-	USD	65 Qtrs
Income (loss) from discontinued operations, tax, period presented	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	-	USD	1 Quarter
Collaboration and research and development revenue	`LicenseAndServicesRevenue`	$3.10M	USD	65 Qtrs
Grant revenue	`RevenueFromGrants`	$3.71M	USD	65 Qtrs
Grant revenue	`RevenueFromGrants`	$38.00K	USD	1 Quarter
Grant revenue	`RevenueFromGrants`	$64.00K	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$6.81M	USD	65 Qtrs
Total revenues	`SalesRevenueNet`	$38.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$64.00K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$7.00M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.53M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.60M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.07M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$190.40M	USD	65 Qtrs
General and administrative	`SellingGeneralAndAdministrativeExpense`	$2.03M	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$5.92M	USD	3 Qtrs
General and administrative	`SellingGeneralAndAdministrativeExpense`	$5.14M	USD	3 Qtrs
General and administrative	`SellingGeneralAndAdministrativeExpense`	$1.81M	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$86.75M	USD	65 Qtrs
Goodwill and intangible impairment	`GoodwillAndIntangibleAssetImpairmentNetDiscontinuedOperations`	$2.75M	USD	65 Qtrs
Restructuring costs	`OtherRestructuringCosts`	$2.63M	USD	65 Qtrs
Total operating expenses	`CostsAndExpenses`	$10.51M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$12.14M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$282.52M	USD	65 Qtrs
Total operating expenses	`CostsAndExpenses`	$3.88M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$3.56M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-275.71M	USD	65 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.52M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-10.45M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-12.14M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.88M	USD	1 Quarter
Costs associated with aborted 2004 IPO	`PaymentsOfFinancingCosts`	$-3.55M	USD	65 Qtrs
Payment under guarantee	`PaymentUnderGuarantee`	$1.65M	USD	65 Qtrs
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$-27.00K	USD	65 Qtrs
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$63.00K	USD	1 Quarter
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$-27.00K	USD	3 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$51.00K	USD	3 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$440.00K	USD	1 Quarter
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$1.00K	USD	1 Quarter
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$6.38M	USD	65 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$643.00K	USD	3 Qtrs
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$237.00K	USD	3 Qtrs
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$6.00K	USD	1 Quarter
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$28.00K	USD	1 Quarter
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$-4.06M	USD	65 Qtrs
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$-59.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$17.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$5.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$33.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$9.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$13.74M	USD	65 Qtrs
Interest expense	`InterestExpense`	$4.57M	USD	65 Qtrs
Other income	`OtherNonoperatingIncome`	$1.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$77.00K	USD	65 Qtrs
Other income	`OtherNonoperatingIncome`	$77.00K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$6.39M	USD	65 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-50.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$617.00K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$409.00K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$477.00K	USD	1 Quarter
Loss from continuing operations before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-11.52M	USD	3 Qtrs
Loss from continuing operations before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-10.04M	USD	3 Qtrs
Loss from continuing operations before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.40M	USD	1 Quarter
Loss from continuing operations before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-269.32M	USD	65 Qtrs
Loss from continuing operations before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.57M	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-443.00K	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-714.00K	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-419.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-19.16M	USD	65 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-126.00K	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-250.16M	USD	65 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-9.33M	USD	3 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-11.08M	USD	3 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-3.15M	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-3.28M	USD	1 Quarter
Income (loss) from discontinued operations, net of tax of $0 for all periods presented	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$1.26M	USD	1 Quarter
Income (loss) from discontinued operations, net of tax of $0 for all periods presented	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$904.00K	USD	3 Qtrs
Income (loss) from discontinued operations, net of tax of $0 for all periods presented	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-168.00K	USD	1 Quarter
Income (loss) from discontinued operations, net of tax of $0 for all periods presented	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-504.00K	USD	3 Qtrs
Income (loss) from discontinued operations, net of tax of $0 for all periods presented	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-11.81M	USD	65 Qtrs
Net loss	`NetIncomeLoss`	$-3.44M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.42M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-261.97M	USD	65 Qtrs
Net loss	`NetIncomeLoss`	$-11.59M	USD	3 Qtrs
Dividends on preferred ordinary shares	`DividendsOnPreferredOrdinaryShares`	$38.12M	USD	65 Qtrs
Deemed dividend on convertible exchangeable preferred shares	`RedeemablePreferredStocksDividends`	$3.52M	USD	65 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$546.00K	USD	3 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$546.00K	USD	3 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$182.00K	USD	1 Quarter
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$182.00K	USD	1 Quarter
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$4.20M	USD	65 Qtrs
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-8.97M	USD	3 Qtrs
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.07M	USD	1 Quarter
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.13M	USD	3 Qtrs
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-307.81M	USD	65 Qtrs
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.63M	USD	1 Quarter
Basic and diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.43	USD	1 Quarter
Basic and diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.37	USD	1 Quarter
Basic and diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-1.13	USD	3 Qtrs
Basic and diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-1.58	USD	3 Qtrs
Basic and diluted (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$0.11	USD	3 Qtrs
Basic and diluted (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.07	USD	3 Qtrs
Basic and diluted (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.02	USD	1 Quarter
Basic and diluted (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$0.15	USD	1 Quarter
Net loss per share - Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.09	USD	3 Qtrs
Net loss per share - Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.25	USD	1 Quarter
Net loss per share - Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.73	USD	3 Qtrs
Net loss per share - Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.47	USD	1 Quarter
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	8.43M	shares	1 Quarter
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	8.23M	shares	3 Qtrs
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.67M	shares	1 Quarter
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.00M	shares	3 Qtrs

Cash Flow Statement 104 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.44M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.42M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-261.97M	USD	65 Qtrs
Net loss	`NetIncomeLoss`	$-11.59M	USD	3 Qtrs
Accretion of interest on notes payable, net of amortization of debt premium	`AccretionExpense`	$100.00K	USD	65 Qtrs
Amortization of investment premiums, net	`InvestmentIncomeAmortizationOfPremium`	$-2.30M	USD	65 Qtrs
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$-27.00K	USD	65 Qtrs
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$63.00K	USD	1 Quarter
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$-27.00K	USD	3 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$51.00K	USD	3 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$440.00K	USD	1 Quarter
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$1.00K	USD	1 Quarter
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$6.38M	USD	65 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$643.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$45.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.60M	USD	65 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$250.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$886.00K	USD	65 Qtrs
Fixed asset impairment	`ImpairmentOfLongLivedAssetsHeldForUse`	$221.00K	USD	65 Qtrs
Unrealized foreign exchange loss	`ForeignCurrencyTransactionGainLossUnrealized`	$-7.75M	USD	65 Qtrs
Unrealized foreign exchange loss	`ForeignCurrencyTransactionGainLossUnrealized`	$29.00K	USD	3 Qtrs
Deferred revenue	`RecognitionOfDeferredRevenue`	$98.00K	USD	65 Qtrs
Compensation for warrants issued to non-employees	`StockOptionPlanExpenses`	$1.22M	USD	65 Qtrs
Shares issued for IP rights	`IssuanceOfStocksAndWarrantsForServicesOrClaims`	$446.00K	USD	65 Qtrs
(Gain) loss on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-38.00K	USD	65 Qtrs
(Gain) loss on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$62.00K	USD	3 Qtrs
Goodwill and intangibles impairment	`GoodwillAndIntangibleAssetImpairment`	$7.93M	USD	65 Qtrs
Stock based compensation	`ShareBasedCompensation`	$287.00K	USD	3 Qtrs
Stock based compensation	`ShareBasedCompensation`	$677.00K	USD	3 Qtrs
Stock based compensation	`ShareBasedCompensation`	$19.31M	USD	65 Qtrs
Provision for restructuring	`PaymentsForRestructuring`	$-1.78M	USD	65 Qtrs
Amortization of issuance costs of Preferred Ordinary "C" shares	`AmortizationOfFinancingCostsAndDiscounts`	$2.52M	USD	65 Qtrs
Transaction costs on sale of Economic Rights	`TransactionCostsOnSaleOfEconomicRights`	$33.00K	USD	65 Qtrs
Transaction costs on sale of Economic Rights	`TransactionCostsOnSaleOfEconomicRights`	$33.00K	USD	3 Qtrs
Gain on termination of distribution agreement	`DisposalGroupIncludingDiscontinuedOperationGainLossOnTerminationOfDistributionAgreement`	$1.19M	USD	3 Qtrs
Gain on termination of distribution agreement	`DisposalGroupIncludingDiscontinuedOperationGainLossOnTerminationOfDistributionAgreement`	$1.19M	USD	65 Qtrs
Prepaid expenses, inventory and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-450.00K	USD	3 Qtrs
Prepaid expenses, inventory and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-25.00K	USD	3 Qtrs
Prepaid expenses, inventory and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$33.00K	USD	65 Qtrs
Accounts payable, accrued liabilities and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$162.00K	USD	3 Qtrs
Accounts payable, accrued liabilities and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-5.53M	USD	65 Qtrs
Accounts payable, accrued liabilities and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-220.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-10.72M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-222.70M	USD	65 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-9.58M	USD	3 Qtrs
Purchase of ALIGN	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.76M	USD	65 Qtrs
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.00K	USD	3 Qtrs
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.85M	USD	65 Qtrs
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.00K	USD	3 Qtrs
Proceeds from sale of property, plant and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$225.00K	USD	65 Qtrs
Proceeds from sale of property, plant and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$62.00K	USD	3 Qtrs
Purchase of short-term investments	`PaymentsToAcquireShortTermInvestments`	$156.66M	USD	65 Qtrs
Redemptions of short-term investments, net of maturities	`ProceedsFromSaleOfShortTermInvestments`	$162.73M	USD	65 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-6.32M	USD	65 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$50.00K	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-6.00K	USD	3 Qtrs
Payment of capital lease obligations	`RepaymentsOfLongTermCapitalLeaseObligations`	$3.72M	USD	65 Qtrs
Proceeds from issuance of ordinary and preferred ordinary shares, net of issuance costs	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$121.68M	USD	65 Qtrs
Proceeds from issuance of common stock, warrants and economic rights, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$9.26M	USD	3 Qtrs
Proceeds from issuance of common stock, warrants and economic rights, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$94.56M	USD	65 Qtrs
Proceeds from issuance of common stock, warrants and economic rights, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$2.89M	USD	3 Qtrs
Net proceeds from stock options and warrants exercised	`ProceedsFromStockOptionsExercised`	$48.00K	USD	3 Qtrs
Net proceeds from stock options and warrants exercised	`ProceedsFromStockOptionsExercised`	$3.00K	USD	3 Qtrs
Net proceeds from stock options and warrants exercised	`ProceedsFromStockOptionsExercised`	$221.00K	USD	65 Qtrs
Payment of preferred stock dividend	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$364.00K	USD	3 Qtrs
Payment of preferred stock dividend	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$1.90M	USD	65 Qtrs
Repayment of government loan	`RepaymentsOfNotesPayable`	$455.00K	USD	65 Qtrs
Government loan received	`ProceedsFromNotesPayable`	$414.00K	USD	65 Qtrs
Loan received from Cyclacel Group Plc	`ProceedsFromLoans`	$9.10M	USD	65 Qtrs
Proceeds of committable loan notes issued from shareholders	`ProceedsOfCommittableLoanNotesIssuedFromShareholders`	$8.88M	USD	65 Qtrs
Loans received from shareholders	`LoansAndLeasesReceivableRelatedPartiesCollections`	$-1.65M	USD	65 Qtrs
Cash and cash equivalents assumed on stock purchase	`CashAcquiredFromAcquisition`	$17.91M	USD	65 Qtrs
Costs associated with stock purchase	`PaymentsForRepurchaseOfEquity`	$1.95M	USD	65 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.93M	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$246.39M	USD	65 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$8.90M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$7.00K	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$462.00K	USD	65 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-12.00K	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$17.84M	USD	65 Qtrs
Net increase (decrease) in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-6.61M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-1.82M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$17.84M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$27.68M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$29.50M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$24.45M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$17.84M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$27.68M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$29.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$24.45M	USD	Point-in-time
Interest	`ProceedsFromInterestReceived`	$10.00K	USD	3 Qtrs
Interest	`ProceedsFromInterestReceived`	$11.76M	USD	65 Qtrs
Interest	`ProceedsFromInterestReceived`	$20.00K	USD	3 Qtrs
Taxes	`ProceedsFromIncomeTaxRefunds`	$18.76M	USD	65 Qtrs
Taxes	`ProceedsFromIncomeTaxRefunds`	$556.00K	USD	3 Qtrs
Taxes	`ProceedsFromIncomeTaxRefunds`	$688.00K	USD	3 Qtrs
Interest	`InterestPaidNet`	$-1.91M	USD	65 Qtrs
Acquisitions of equipment purchased through capital leases	`AcquisitionsOfEquipmentPurchasedThroughCapitalLeases`	$3.47M	USD	65 Qtrs
Issuance of common shares in connection with license agreements	`IssuanceOfOrdinarySharesInConnectionWithLicenseAgreements`	$592.00K	USD	65 Qtrs
Issuance of ordinary shares on conversion of bridging loan	`IssuanceOfOrdinarySharesOnConversionOfBridgingLoan`	$1.64M	USD	65 Qtrs
Issuance of preferred ordinary "C" shares on conversion of secured convertible loan notes and accrued interest	`IssuanceOfPreferredOrdinaryClassCSharesOnConversionOfSecuredConvertibleLoanNotesAndAccruedInterest`	$8.89M	USD	65 Qtrs
Issuance of ordinary shares in lieu of cash bonus	`IssuanceOfOrdinarySharesInLieuOfCashBonus`	$164.00K	USD	65 Qtrs
Issuance of other long term payable on ALIGN acquisition	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	$1.12M	USD	65 Qtrs

Comprehensive Income 5 line items

Line Item	Tag	Value	Unit	Period
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-11.57M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-261.92M	USD	65 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.43M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.92M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.44M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.